NCT04391920 - Registry of CytoSorb Therapy in COVID-19 ICU Patients | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions

COVID-19

Interventions

DEVICE

CytoSorb 300 mL device

CytoSorb hemoadsorption provided via integration of the CytoSorb device into ECMO, CRRT, or hemoperfusion extracorporeal circuits.

Trial Locations (7)

New York University Medical Center, New York

West Virginia University, Morgantown

Baptist Memorial Hospital, Southaven

Franciscan Health Indianapolis, Indianapolis

Medical College of Wisconsin, Milwaukee

University of Chicago Medicine, Chicago

Medical Center of Aurora, Aurora